Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins

被引:177
作者
Bernasconi, M
Remppis, A
Fredericks, WJ
Rauscher, FJ
Schafer, BW
机构
[1] UNIV ZURICH, DEPT PEDIAT, DIV CLIN CHEM, CH-8032 ZURICH, SWITZERLAND
[2] WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1073/pnas.93.23.13164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The expression of a number of human paired box-containing (PAX) genes has been correlated with various types of tumors, Novel fusion genes encoding chimeric fusion proteins have been found in the pediatric malignant tumor alveolar rhabdomyosarcoma (RMS). They are generated by two chromosomal translocations t(2;13) and t(1;13) juxtaposing PAX3 or PAX7, respectively, with a forkhead domain gene FKHR. Here we describe that specific down-regulation of the t(2;13) translocation product in alveolar RMS cells by antisense oligonucleotides results in reduced cellular viability, Cells of embryonal RMS, the other major histiotype of this tumor, were found to express either wild type PAX3 or PAX7 at elevated levels when compared with primary human myoblasts, Treatment of corresponding embryonal RMS cells with antisense olignucleotides directed against the mRNA translational start site of either one of these two transcription factors similarly triggers cell death, which is most likely due to induction of apoptosis, Retroviral mediated ectopic expression of mouse Pax3 in a PAX7 expressing embryonal RMS cell line could partially rescue antisense induced apoptosis. These data suggest that the PAX3/FKHR fusion gene and wild-type PAX genes play a causative role in the formation of RMS and presumably other tumor types, possibly by suppressing the apoptotic program that would normally eliminate these cells.
引用
收藏
页码:13164 / 13169
页数:6
相关论文
共 34 条
  • [1] BOBER E, 1994, DEVELOPMENT, V120, P603
  • [2] THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM
    BURGESS, TL
    FISHER, EF
    ROSS, SL
    BREADY, JV
    QIAN, YX
    BAYEWITCH, LA
    COHEN, AM
    HERRERA, CJ
    HU, SSF
    KRAMER, TB
    LOTT, FD
    MARTIN, FH
    PIERCE, GF
    SIMONET, L
    FARRELL, CL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 4051 - 4055
  • [3] PAX-3 CONTAINS DOMAINS FOR TRANSCRIPTION ACTIVATION AND TRANSCRIPTION INHIBITION
    CHALEPAKIS, G
    JONES, FS
    EDELMAN, GM
    GRUSS, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12745 - 12749
  • [4] CORDONCARDO C, 1995, AM J PATHOL, V147, P545
  • [5] DAVIS RJ, 1994, CANCER RES, V54, P2869
  • [6] PAX-2 IS A DNA-BINDING PROTEIN EXPRESSED IN EMBRYONIC KIDNEY AND WILMS-TUMOR
    DRESSLER, GR
    DOUGLASS, EC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) : 1179 - 1183
  • [7] WT1 SUPPRESSES SYNTHESIS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND INDUCES APOPTOSIS
    ENGLERT, C
    HOU, X
    MAHESWARAN, S
    BENNETT, P
    NGWU, C
    RE, GG
    GARVIN, AJ
    ROSNER, MR
    HABER, DA
    [J]. EMBO JOURNAL, 1995, 14 (19) : 4662 - 4675
  • [8] PAX3 INHIBITS MYOGENIC DIFFERENTIATION OF CULTURED MYOBLAST CELLS
    EPSTEIN, JA
    LAM, P
    JEPEAL, L
    MAAS, RL
    SHAPIRO, DN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) : 11719 - 11722
  • [9] APOPTOSIS AND THE CELL-CYCLE
    EVAN, GI
    BROWN, L
    WHYTE, M
    HARRINGTON, E
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) : 825 - 834
  • [10] FABBRO D, 1994, CANCER RES, V54, P4744